Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Valion Bio (TIVC) Shares Issued (2021 - 2025)

Valion Bio has reported Shares Issued over the past 4 years, most recently at -$109000.0 for Q4 2025.

For Q4 2025, Shares Issued fell 102.49% year-over-year to -$109000.0; the TTM value through Sep 2025 reached $4.5 million, up 321.6%, while the annual FY2024 figure was $4.4 million, 48.5% down from the prior year.
Shares Issued for Q4 2025 was -$109000.0 at Valion Bio, down from $109000.0 in the prior quarter.
Over five years, Shares Issued peaked at $14.8 million in Q4 2021 and troughed at -$3.3 million in Q3 2024.
A 4-year average of $2.7 million and a median of $109000.0 in 2025 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: tumbled 175.32% in 2024 and later tumbled 102.49% in 2025.
Year by year, Shares Issued stood at $14.8 million in 2021, then crashed by 70.89% to $4.3 million in 2023, then grew by 1.51% to $4.4 million in 2024, then tumbled by 102.49% to -$109000.0 in 2025.
Business Quant data shows Shares Issued for TIVC at -$109000.0 in Q4 2025, $109000.0 in Q1 2025, and $4.4 million in Q4 2024.